SAN DIEGO, Sept. 20 /PRNewswire-FirstCall/ -- Biosite Incorporated
(Nasdaq: BSTE) will host its 3rd Annual Investor R&D Day Conference:
Establishing Excellence in Diagnostic Innovation, on Tuesday, October 3,
2006, beginning at 9:00 AM Eastern Daylight Time.
This year's program will be moderated by Norman Paradis, M.D.,
Biosite's vice president of medical affairs. A schedule of the day, with
topics and speakers, is available at
http://www.biosite.com/investor/randd.aspx.
Investors and other interested parties may access this meeting by
visiting the Company's Web site at http://www.biosite.com for a simultaneous
webcast of the presentations. If you are unable to participate during the
live webcast, the conference will be archived on the Biosite Web site until
November 4, 2006.
Contact: Michelle Hickman
Corporate and Investor Relations
Biosite Incorporated
(858) 805-2419
email: mhickman@biosite.com
About Biosite Incorporated
Biosite Incorporated is a leading bio-medical company commercializing
proteomics discoveries for the advancement of medical diagnosis. The
Company's products contribute to improvements in medical care by aiding
physicians in the diagnosis of critical diseases and health conditions.
Biosite's Triage(R) rapid diagnostics are used in approximately 50 percent
of U.S. hospitals and in more than 60 international markets. Information on
Biosite can be found at http://www.biosite.com.
Biosite(R), Triage(R) and New Dimensions in Diagnosis(R) are registered
trademarks of Biosite Incorporated. The Company's logo is a trademark of
Biosite Incorporated.
SOURCE Biosite Incorporated
 back to top
Related links:
http://www.biosite.com/investor/randd.aspx
http://www.biosite.com
http://www.prnewswire.com/comp/116737.html /
CONTACT:
Nadine Padilla, Vice President, Corporate and
Investor Relations, +1-858-805-2820, npadilla@biosite.com, or
Michelle Hickman, Investor Relations Analyst, +1-858-805-2419,
mhickman@biosite.com, both of Biosite Incorporated
|
